About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in California | 51,452 Studies Near You

Clinical TrialsCalifornia

Clinical Trials in California

Discover 51,452 clinical trials near California. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1341-1360 of 51,452 trials

UnknownPREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT)Prospective, multi-center-observational study conducted within the US, collecting patient samples for research and development to train, test, and validate precision medicine…NCT06390709·Whittier, California RecruitingATEMPT 2.0: Adjuvant T-DM1 vs THThis research study is studying how well newly diagnosed breast cancer that has tested positive for a protein called HER2 responds using one of two different combination of…NCT04893109·San Francisco, California and 52 others

Find Trials by Condition in California

Breast Cancerin California Lung Cancerin California Prostate Cancerin California Colorectal Cancerin California Melanomain California Leukemiain California Lymphomain California Pancreatic Cancerin California Ovarian Cancerin California Brain Cancerin California

Data from ClinicalTrials.govTerms

CompletedQUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid CancersPhase 1 study to assess the safety, preliminary efficacy of PD-L1 t-haNK and to determine the maximal tolerated dose and designate the recommended phase 2 dose in subjects with…NCT04050709·El Segundo, California

TerminatedMotor Evoked Potentials and SedLineTo determine if using usual clinical practice plus a depth of anesthesia monitor, SedLine, to guide anesthetic administration improves the quality and ease of MEP monitoring in…NCT00805844·San Francisco, California

CompletedAn Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib ProtocolThis open-label, multicenter, non-randomized study provided continued access to vemurafenib for eligible participants with BRAF V600 mutation-positive malignancy, who were…NCT01739764·Rogers, Arkansas and 82 others

CompletedEvaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%The objective of this study is to evaluate the clinical equivalence and safety of the Test formulation of diclofenac sodium topical gel 1% (Anchen Pharmaceuticals, Inc.) compared…NCT01456611·Birmingham, Alabama and 56 others

CompletedStudy of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous DiseaseChronic Granulomatous Disease (CGD) is an inherited immunodeficiency disorder which results from defects that prevent white blood cells from effectively killing bacteria, fungi…NCT02234934·Los Angeles, California and 2 others

CompletedScripps Polster Breast Care Center Investigational GeneBankBreast cancer is a disease of complex origin with a strong genetic component.NCT00945464·La Jolla, California

CompletedEGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerThis phase I trial studies the side effects and the best dose of giving EGEN-001 together with pegylated liposomal doxorubicin hydrochloride in treating patients with ovarian…NCT01489371·Birmingham, Alabama and 6 others

CompletedCOVID-19 and Venous Thromboembolism RiskCoronavirus disease 2019 (Covid-19) is now a leading cause of death among U.S. adults.NCT04569344·Oakland, California and 1 other

Completed6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary InsomniaTo evaluate the long-term efficacy of eszopiclone administered for up to 6 months in subjects with primary insomnia on subjective sleep measures, compared to placebo.NCT00352144·Birmingham, Alabama and 57 others

CompletedNiche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere TrialA pivotal, prospective, multi-center, randomized, controlled, double-blinded study combining active Nexstim NBS-guided 1Hz rTMS or sham-rTMS targeting the healthy hemisphere with…NCT02089464·Phoenix, Arizona and 11 others

TerminatedA Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed DosingThis is a one-year study to look at the safety of a dry powder inhaler with albuterol.NCT01218009·Scottsdale, Arizona and 29 others

CompletedA Study of LY3561774 in Participants With DyslipidemiaThis is a 3-part study.NCT04644809·Cypress, California and 4 others

Not yet recruitingVibrotactile Coordinated Reset for Spasticity After Spinal Cord InjuryThe purpose of our study is to evaluate vibrotactile Coordinated Reset (vCR) and its effects on spasticity symptoms in incomplete spinal cord injured patients. vCR will be…NCT06290609·Stanford, California

TerminatedStudy of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal MalignanciesThe available data indicate that Ceritinib has substantial anti-tumor activity in patients with anaplastic lymphoma kinase (ALK) and ROS1 rearranged non-small cell lung cancer…NCT02638909·Los Angeles, California and 5 others

RecruitingQualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUDThis study will attempt to identify social facilitators and barriers to detection and treatment of non-small cell lung cancer in order to learn how a history of substance abuse or…NCT07186699·Los Angeles, California and 1 other

CompletedPhase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and AlbuminuriaThe primary objective of this study is to assess the effect of 2 dose levels of TMX-049 on urinary albumin excretion in subjects with Type 2 diabetes and albuminuria (a urinary…NCT03449199·Flagstaff, Arizona and 54 others

CompletedIntroducing Palliative Care (PC) Within the Treatment of End Stage Liver Disease (ESLD)This is a comparative effectiveness study of two pragmatic models aiming to introduce palliative care for end stage liver disease patients.NCT03540771·Birmingham, Alabama and 18 others

Active not recruitingNivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)This phase III ALCHEMIST treatment trial studies how well nivolumab after surgery and chemotherapy work in treating patients with stage IB-IIIA non-small cell lung cancer.NCT02595944·Birmingham, Alabama and 883 others

PreviousPage 68 of 2573Next

Diabetes

in California

Heart Diseasein California